<b>Conclusions</b>: GLP-1 RA use was associated with a significantly reduced incidence of pancreatic cancer in all patients with CP, as well as the subpopulation with both CP and T2DM. The gene discussed is GLP1R; the disease is familial pancreatic carcinoma.